The Macromolecular Therapeutics Development Facility (MTDF) provides expertise for directed development and optimization of protein-based therapeutics and supports high-throughput automated development, analysis and production of protein reagents using a Bioemk FxP liquid handling workstation for HTP molecular biology and expression testing, a Perkin-Elmer Cell::Explorer robot for very efficient HTP tissue culture based application and a custom microarray printer. This automation is designed to provide Einstein researchers with the added leverage of robotics equipment and trained personnel to accelerate and scale up their projects, thereby obviating the need for individual investigators to set up and staff their own facilities for protein production.
Price Center/Block Research Pavillion 313
Scientific Director
Steven C. Almo, Ph.D.
718.430.2746
steve.almo@einsteinmed.org
Operations Director
Scott Garforth, Ph.D.
718.678.1146
scott.garforth@einsteinmed.org
Co-Scientific Director (Monoclonal Antibodies)
Matthew D. Scharff, M.D.
718.430.3527
matthew.scharff@einsteinmed.org
Associate Director (Monoclonal Antibodies)
Susan Buhl
718.430.2170
susan.buhl@einsteinmed.org
Journal of Immunological Methods,2006 Oct; 316(1-2):59-66
Tablet Blog